Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
12/2003
12/09/2003US6660471 Enhanced replication of HCV RNA
12/09/2003US6660273 Viable chimeric recombinant flavivirus
12/09/2003US6660272 For protection against Porcine Multisystemic Wasting Syndrome also called Post- weaning Multisystemic Wasting Syndrome
12/09/2003US6660264 Treatment of intracellular infection
12/09/2003US6660259 Herpes simplex virus for treating unwanted hyperproliferative cell growth
12/09/2003CA2111580C Immunogen composites with noted anticytokin effect, process of preparation, pharmaceutical compositions and kits containing them
12/04/2003WO2003100042A1 Method for assembling sub units into capsoides
12/04/2003WO2003099859A2 Novel use of adenoviruses and nucleic acids coding therefor
12/04/2003WO2003098991A2 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability
12/04/2003WO2003066810A3 Recombinant bovine immunodeficiency virus based gene transfer system
12/04/2003WO2003063679A3 Hepatitis e virus clones and methods of their use
12/04/2003WO2003016491A3 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
12/04/2003WO2003002746A3 Perv screening method and use thereof
12/04/2003WO2002036806A9 Expression vectors able to elicit improved immune response and methods of using same
12/04/2003WO1999013818A3 Membrane virus host range mutations and their uses as vaccine substrates
12/04/2003US20030225260 Production of recombinant AAV virions
12/04/2003US20030224502 Recovery of virus from cell culture using a hypertonic salt solution
12/04/2003US20030224354 Quantifying viral particles with intrinsic fluorescence
12/04/2003US20030224352 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes
12/04/2003US20030224018 Modified Vaccinia Virus Ankara for the vaccination of neonates
12/04/2003US20030224017 Recombinant Newcastle disease viruses useful as vaccines or vaccine vectors
12/04/2003US20030224015 Administering to a mammal an immunogenic formulation containing an Ebola peptide, to induce a protective cytotoxic T lymphocyte response
12/04/2003US20030223987 Immunodeficiency recombinant poxvirus
12/04/2003US20030223977 Novel small proteins which bind cathepsin G have been identified. These are useful as inhibitors of excessive cathepsin G activity in patients.
12/04/2003US20030223971 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors
12/04/2003US20030223964 Efficient expression of HIV polypeptides in a variety of cell types, including, but not limited to, mammalian, insect, and plant cells. Synthetic expression cassettes encoding the HIV Gag-containing polypeptides are described, as are uses of the
12/04/2003CA2513388A1 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability
12/04/2003CA2487811A1 Use of adenoviruses replicating in a yb-1 dependent manner for the treatment of tumors
12/04/2003CA2487283A1 Method for assembling sub units into capsoides
12/03/2003EP1366177A1 Cloning vectors and method for molecular cloning
12/03/2003EP1366171A2 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells
12/03/2003EP1366170A1 Use of flavivirus for the expression of protein epitopes and development of new live attenuated vaccine virus to immune against flavivirus and other infectious agents
12/03/2003EP1250292B1 Process to prevent microorganisms blooming in an aquatic system
12/02/2003US6656727 A retroviral vector of a heterologous nucleic acid sequence as well as at least one sequence allowing site-specific integration of the sequence into a non-coding region of a genome; gene therapy of genetic defects; viricides
12/02/2003US6656720 For use in vaccines
12/02/2003US6656719 Serum-free, low-protein media for rotavirus vaccine production
12/02/2003US6656706 Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
12/02/2003US6656476 Vaccine against Mumps containing a Jeryl-Lynn virus strain
12/02/2003US6656463 Administering 5 Felix 0-1 Phage (F01 phage) in acceptable carrier to a livestock animal to reduce or prevent dissemination of Salmonella
12/02/2003CA2099268C Fusions of a viral protein and a destructive enzyme
11/2003
11/27/2003WO2003097846A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003WO2003097845A1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
11/27/2003WO2003097844A1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
11/27/2003WO2003097797A2 Methods of adenovirus purification
11/27/2003WO2003097090A1 Use of modified novirhabdoviruses to obtain vaccines
11/27/2003WO2003097089A2 Attenuation of metapneumovirus
11/27/2003WO2003096969A2 Novel lambda phage display system and the process
11/27/2003WO2003023040A3 Vaccinia virus mva-e3l-knockout-mutants and use thereof
11/27/2003WO2003020204A3 Detection of bovine viral diarrhea virus in tissue samples
11/27/2003WO2003010200A3 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
11/27/2003WO2002064805A3 Replication competent non-mammalian retroviral vectors
11/27/2003WO2000062735A3 Treatment of neoplasms with viruses
11/27/2003US20030220276 HIV vaccine and method of use
11/27/2003US20030219886 Directed evolution of novel binding proteins
11/27/2003US20030219873 Self-assembling recombinant papillomavirus capsid proteins
11/27/2003US20030219735 Genetically engineered adeno-associated viral vector comprising single stranded heterologous nucleotide sequence for use as tool diagnostic tool in gene therapy and genomic screening
11/27/2003US20030219732 Adaptation sites of porcine reproductive and respiratory syndrome virus
11/27/2003US20030219722 Comprises preparation of novel binding prolypeptides via mutagenesis, expression, chromatographic selection and amplification; drug screening
11/27/2003US20030219460 Cotton rat lung cells for virus culture
11/27/2003US20030219458 Multivalent vaccination using recombinant adenovirus
11/27/2003US20030219426 Endostatins used as antiproliferative agents or angiogenesis inhibitors for prophylaxis of tumors, or as contraceptives
11/27/2003US20030219415 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions
11/27/2003US20030219412 Somatic gene therapy to suppress secondary cataract formation following eye surgery
11/27/2003US20030217926 Recovery of viruses
11/27/2003CA2812019A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003CA2484295A1 Attenuation of metapneumovirus
11/27/2003CA2483712A1 Use of modified novirhabdoviruses to obtain vaccines
11/27/2003CA2481799A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003CA2481783A1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
11/26/2003EP1364944A1 Frangible Compounds for Pathogen Inactivation
11/26/2003EP1364038A2 Adenovirus particles with mutagenized fiber proteins
11/26/2003EP1364037A2 Methods and compositions useful for stimulating an immune response
11/26/2003EP1364031A1 Hiv-like particles and the use thereof
11/26/2003EP1364006A2 Methods to identify mutant cells with altered sialic acid
11/26/2003EP1363997A1 Concentration and lysis of adenovirus-infected cells in a single unit operation
11/26/2003EP1363944A2 High-affinity antagonists of elr-cxc chemokines
11/26/2003EP1363937A2 Immunomodulating agents from parasitic worms and method for isolation thereof
11/26/2003EP1363662A2 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo ; analysis of vaccinating composition in vitro
11/25/2003US6653130 Method for the development of an HIV vaccine
11/25/2003US6653118 Deoxyribonuclease, gene encoding same and use thereof
11/25/2003US6653104 Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells
11/25/2003US6653072 Improving expression of a protein encoded by DNA substrate by assembling oligonucleotides into recombinant nucleic acids and using it to transform cells; recursive sequence recombination
11/25/2003US6653069 Method for quality control of an attenuated vericella live vaccine
11/20/2003WO2003095971A2 Posh nucleic acids, polypeptides and related methods
11/20/2003WO2003095656A1 Recombinant fowlpox virus
11/20/2003WO2003095623A2 Genetically engineered cell lines and systems for propagating varicella zoster virus and methods of use thereof
11/20/2003WO2003084479A3 Large scale methods of producing adenovirus and adenovirus seed stocks
11/20/2003WO2003046124A3 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
11/20/2003WO2003041830A3 Macroporous gel, its preparation and its use
11/20/2003WO2003039459A3 Viral vector production methods and compositions
11/20/2003WO2003039458A3 TREATMENT OF HUMAN CANCER WITH ADENOVIRAL VECTOR EXPRESSING TNF-α
11/20/2003WO2003031567A3 Precursor conversion screening methods
11/20/2003WO2003023041A3 Infectious and attenuated bovine viral diarrhea virus clone; methods for their production and use
11/20/2003WO2003012054A3 Methods and compositions relating to improved lentiviral vector production systems
11/20/2003WO2003004627B1 Novel human hepatoma lines, methods for obtaining same and uses thereof
11/20/2003WO2002083736A3 G-protein coupled receptor molecules and uses thereof
11/20/2003WO2002077246A3 Site-targeted transformation using amplification vectors
11/20/2003WO2002052015A3 Self-replicating rna molecule from hepatitis c virus
11/20/2003US20030216338 Bacteriophage having multiple host range
11/20/2003US20030216322 Containing the motif E(L/V/S)RGDS
1 ... 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 ... 267